Prosiectau (33)
Cardiff University Schools involved in this Project
Optimising the diagnosis of a symptomatic cancer (01.01.2010 - 31.12.2012)
Organisational culture in the NHS: A feasibility study to measure the impact on older people (01.08.2010 - 31.08.2012)
- O'Mahony, Sinead
Optimising the tolerogic potential of the dermal route of administration in the development of a diabetes vaccine (01.10.2010 - 31.10.2011)
- Dayan, Colin
OB1-1 dose-response in inhibitor plasma in-vitro study (04.08.2011 - 03.03.2012)
- Collins, Peter
Optimisation of positron emission tomography based target volume delineation in head and neck radiotherapy (01.09.2011 - 31.08.2014)
- Mason, Malcolm
Option grids: easy to use shared decision making tools for disadvantaged groups (01.01.2012 - 31.07.2022)
-
- Harding, Keith
Optimising Psoriasis referrals from primary care: Dermatology life quality index as a triage tool (01.04.2012 - 31.03.2014)
- Ingram, John
One year likelihood of relapse in ulcerative colitis (UC) is predicted by mucosal appearance but not by faecal calprotectin: Data from the coda study of once daily versus three times daily asacol (28.11.2012 - 27.02.2013)
- Gillespie, David
Oral steroids for resolution of otitis media with effusion (OME) in children: The OSTRICH study (01.03.2013 - 31.12.2018)
- Francis, Nicholas
Objective assessment of the neuropsychiatric symptoms in Huntington's disease (02.09.2013 - 29.06.2018)
- McLauchlan, Duncan
Optimising the herpesvirus-specific CF8+ T-cell response by targeting the IL-10R pathway (01.09.2014 - 21.12.2019)
- Humphreys, Ian
Optimising the patient journey with cancer associated Thrombosis (TOPCAT) (01.04.2015 - 31.10.2016)
- Noble, Simon
One heat and moisture exchanger filter sample (12.10.2015 - 11.05.2016)
- Hall, Judith
Optimisation of alternative pathway assays for monitoring agent effect (12.07.2016 - 31.12.2017)
- Morgan, Paul
-
- Ottmann, Oliver
One-week exercise training induces white matter microstructural and blood flow changes: a multi-modal MRI study (01.01.2017 - 31.12.2017)
- Steventon, Jessica
Optimised peptide and non-peptide ligands for vaccination (01.09.2018 - 31.12.2019)
- Sewell, Andrew
Observational study to investigate surgical site infection in ulcerated skin cancers (OASIS) (01.12.2018 - 31.07.2021)
- Thomas-Jones, Emma
Observational chart review of patients with Rheumatoid Arthritis treated with Abatacept (28.02.2019 - 31.12.2019)
- Choy, Ernest
Overexpression of capillary morphogenesis gene 2 (CMG2) enhances tumour cell-orientated tumour microenvironment during tumour genesis and metastasis of pancreatic cancer (01.04.2019 - 31.12.2020)
- Ye, Lin
Optimisation of molecular testing in newly-diagnosed acute myeloid leukaemia (AML) in Wales (01.06.2019 - 31.12.2021)
- Knapper, Steven
Optimization of scanning with CZT gamma cameras to improve the detection of metastatic spread to the bone in a range of cancers (01.07.2019 - 30.06.2024)
- Marshall, Christopher
Optimizing outcomes in children of depressed parents: Identification of modifiable promoters of sustained mental health resilience (01.10.2020 - 30.09.2024)
- Collishaw, Stephan
Optimal Clinical Trials Platform for Progressive Multiple Sclerosis -OCTOPUS (01.01.2021 - 31.12.2028)
- Tallantyre, Emma
Optimization of Cas9 for in vivo delivery and gene editing (01.07.2021 - 30.06.2023)
- Dion, Vincent
OECD PaRIS- SUR: International survey on outcomes and experiences of patients with chronic conditions (01.08.2022 - 31.03.2023)
- Carson-Stevens, Andrew
OHOK our health our knowledge evaluation project (01.10.2022 - 30.11.2022)
- Ashfield-Watt, Pauline
Optimising a novel antiviral immunotherapy (01.10.2022 - 30.09.2026)
- Stanton, Richard
OnTrack Rehab: A digital system for upper limb rehabilitation after stroke (15.12.2022 - 31.10.2024)
- Lowe, Rachel
Optimisation and feasibility of Triple P parenting programme for remote delivery (01.03.2023 - 31.07.2024)
- Segrott, Jeremy
Optimise-FLT3 Study: Optimising therapy for patients with FLT3-mutated Acute Myeloid Leukaemia (01.03.2024 - 28.02.2031)
- Knapper, Steven
Optimising Immunotherapy of Breast Cancer Through Combining Regulatory T Cell Depletion with Targeting the Co-Inhibitory Receptor, LAG-3 (01.05.2024 - 30.04.2027)
- Gallimore, Awen